The aims of our investigations were to determine the oncogenic potential of cancer patients’ sera on BRCA1-KO human fibroblasts, to characterize their differentiation following serum treatments and evaluate their phenotypes, and to determine their receptiveness to integrate serum-carried factors, such as exosomes. This evidence concerns the gene BRCA1 and cancer.